Automotive and Transportation Automotive and Transportation

Is Immatics N.V. (IMTX) Among Billionaire Joseph Edelman's Long-Term Stock Picks?


Published on 2025-01-20 15:41:44 - MSN
  Print publication without navigation

  • We recently published a list of Billionaire Joseph Edelman's Top 10 Long-Term Stock Picks. In this article, we are going to take a look at where Immatics N.V. (NASDAQ:IMTX) stands against other Billionaire Joseph Edelman's long-term stock picks.

The article discusses whether Immatics N.V. (IMTX) is among billionaire Joseph Edelman's long-term stock picks. Immatics, a clinical-stage biopharmaceutical company, focuses on the development of T-cell receptor (TCR) therapies for cancer treatment. The piece highlights that Edelman, through his hedge fund Perceptive Advisors, has shown interest in Immatics, which could be inferred from his investment strategies and past stock selections. It notes that while Edelman's exact current holdings are not publicly detailed, his history of investing in biotech and healthcare sectors, particularly in innovative treatments like those developed by Immatics, suggests a potential long-term interest. The article also touches on Immatics' recent developments, including promising clinical trial results, which might attract investors like Edelman who look for companies with strong growth potential in the biotech space. However, it does not confirm definitively that Immatics is part of his long-term portfolio.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/savingandinvesting/is-immatics-n-v-imtx-among-billionaire-joseph-edelman-s-long-term-stock-picks/ar-AA1xxxOL ]